VestGen Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.62M Sell
5,230
-635
-11% -$305K 0.08% 249
2026
Q1
$2.69M Buy
5,865
+502
+9% +$272K 0.07% 240
2025
Q4
$3.11M Sell
5,363
-315
-6% -$178K 0.13% 161
2025
Q3
$2.75M Buy
5,678
+1,131
+25% +$526K 0.09% 203
2025
Q2
$1.84M Sell
4,547
-175
-4% -$73.2K 0.07% 225
2025
Q1
$2.35M Buy
+4,722
New +$2.56M 0.11% 169

Other funds holding TMO

VestGen Advisors's TMO Position: Q2 2026 in Review

VestGen Advisors reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, selling an estimated $305K and leaving 5,230 shares worth $2.62M. The position accounts for 0.08% of the portfolio, ranked #249.

VestGen Advisors first reported a position in TMO in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.11M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • VestGen Advisors held 5,230 shares of Thermo Fisher Scientific worth $2.62M as of Q2 2026.
  • VestGen Advisors sold 635 Thermo Fisher Scientific shares in Q2 2026, an estimated $305K.
  • Thermo Fisher Scientific made up 0.08% of VestGen Advisors's portfolio in Q2 2026, its #249 holding.
  • VestGen Advisors first reported a position in Thermo Fisher Scientific in Q1 2025 and has held it in 6 quarters since.
  • VestGen Advisors's Thermo Fisher Scientific position peaked at $3.11M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.